Dr. Ines Sanchez-Rivera, M.D.
What this data tells you about Dr. Sanchez-Rivera
Dr. Ines Sanchez-Rivera is an optician in El Paso, TX, with 20 years in practice. Based on federal Medicare data, Dr. Sanchez-Rivera performed 4,288 Medicare services across 1,088 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sanchez-Rivera received a total of $27,448 from 20 pharmaceutical and/or device companies across 59 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sanchez-Rivera is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 960 | $18 | $66 |
| Blood draw (venipuncture) | 415 | $8 | $20 |
| Dexamethasone injection (steroid) | 400 | $0 | $1 |
| Complete blood count (CBC) with differential | 379 | $7 | $36 |
| Injection, granisetron hydrochloride, 100 mcg | 340 | $0 | $24 |
| Comprehensive metabolic blood panel | 330 | $10 | $64 |
| Office visit, established patient (20-29 min) | 227 | $59 | $250 |
| Office visit, established patient (30-39 min) | 193 | $86 | $368 |
| Anti-nausea injection (Aloxi/palonosetron) | 190 | $1 | $114 |
| Injection of additional new drug or substance into vein | 152 | $12 | $108 |
| Administration of chemotherapy into vein, 1 hour or less | 99 | $96 | $707 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 72 | $55 | $211 |
| Ferritin level test (iron stores) | 48 | $13 | $60 |
| Iron level test | 44 | $6 | $27 |
| Iron binding capacity test | 44 | $9 | $35 |
| Injection, diphenhydramine hcl, up to 50 mg | 41 | $1 | $7 |
| Drug injection, under skin or into muscle | 37 | $10 | $96 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 32 | $272 | $2,762 |
| Reticulated (young) platelet measurement | 31 | $35 | $143 |
| Irrigation of implanted venous access drug delivery device | 30 | $15 | $114 |
| Carcinoembryonic antigen (cea) protein level | 29 | $19 | $99 |
| Administration of chemotherapy into vein, each additional hour | 27 | $21 | $161 |
| Lactate dehydrogenase (enzyme) level | 23 | $6 | $31 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 22 | $26 | $145 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 19 | $22 | $157 |
| Administration of additional new drug or substance into vein, 1 hour or less | 19 | $49 | $344 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 17 | $20 | $128 |
| New patient office visit (45-59 min) | 16 | $115 | $565 |
| Initial hospital admission, moderate complexity | 16 | $100 | $470 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 13 | $45 | $313 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | 12 | $177 | $700 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 11 | $90 | $657 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (94%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 7% for optician in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Sanchez-Rivera is a mixed practice specialist, with above-average Medicare volume (top 16% in TX), and high industry engagement (consulting-driven, top 7%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Sanchez-Rivera experienced with denosumab injection (prolia/xgeva)?
Does Dr. Sanchez-Rivera receive payments from pharmaceutical companies?
How do Dr. Sanchez-Rivera's costs compare to other opticians in El Paso?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology